Marit van Buuren: Former BioNTech Teammates Are Talented Innovators Seeking New Opportunities
Marit van Buuren, Senior Director of T Cell Immunology and Process Development at BioNTech SE, shared a post on LinkedIn:
“Last week, BioNTech announced a strategic reorganization of the US organization, and many dear colleagues have been impacted by this. I’m so sad and want to show my support to those affected.
As people post on LinkedIn, you’ll see me like and share them to make sure my network gets exposure to this incredible group of people. Each of these colleagues is passionate and has consistently driven innovation and success within BioNTech, contributing to helping patients every single day.
I’ve been fortunate to witness their dedication first-hand, from launching critical projects to enhancing patient care, first at Neon and then BioNTech. They are now looking for new places to apply their talents, and much more!
If you have open positions in your organization, don’t miss out on this group. Please reach out if you’re interested in connecting or can offer opportunities. I am confident that these individuals will bring immense value to their next ventures and will continue to make a difference.”
More posts featuring Marit van Buuren.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023